In the wake of a wave of deaths related to synthetic cannabis overdoses, the Illinois Senate approved a plan b to broaden the classification of such drugs, which often skirt the law through minute tweaks to their formulae.
“After the careful consideration taken to weigh the implications of new restrictions on drugs, I want to thank my colleagues in the Senate for swiftly passing this legislation, and I urge the House to do the same,” said Sen. Jacqueline Collins (D-Chicago), who sponsored the bill. “Many synthetic cannabinoids are already illegal, but by broadening the criteria, we ensure that they can’t be made legal by small and potentially deadly changes to their chemical formulae.”
Since March, news reports throughout the Midwest have told of the use of synthetic cannabinoids – called by names like “fake weed” and “K2” – leading to deaths and severe hemorrhaging. The Centers for Disease Control reported that 99 percent of these cases have occurred in Illinois.
“We can’t afford to be stuck in a cycle of reacting to these irresponsible and deadly chemistry experiments,” Collins said. “We must act now to stop future deaths.”
The measure, Senate Bill 2341, would add all synthetic cannabinoids to the Controlled Substances Act and make synthetics subject to emergency controlled substance scheduling. Manufacturers would be subject to a Class 3 felony charge, while those charged with simple possession would face a Class 4 felony.
The measure passed the Senate without opposition. It is scheduled for consideration in the House.
